Skip to main content
. 2024 Nov 26;16(11):e74522. doi: 10.7759/cureus.74522

Table 2. Distribution of study subjects according to CBNAAT.

CBNAAT: cartridge-based nucleic acid amplification tests; TBM: tubercular meningitis

CBNAAT Category Frequency Percentage (%)
Positive Definite 80 53.3
Negative Probable 46 30.7
Possible 21 14
Non-TBM 3 2